ESPERION THERAPEUTICS INC. - COMMON STOCK

Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

11 يناير 2026 18:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

08 يناير 2026 10:53:57 بحسب NetDania Notify

Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference

05 يناير 2026 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion’s Bempedoic Acid Receives Recommendation in 2025 ACC Scientific Statement on Management of Peripheral Artery Disease in Adults With Diabetes

19 ديسمبر 2025 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

12 ديسمبر 2025 09:47:52 بحسب NetDania Notify

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

11 ديسمبر 2025 13:57:31 بحسب NetDania Notify

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

09 ديسمبر 2025 16:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

01 ديسمبر 2025 09:58:15 بحسب NetDania Notify

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

28 نوفمبر 2025 09:58:36 بحسب NetDania Notify

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

26 نوفمبر 2025 11:43:59 بحسب NetDania Notify

Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia

21 نوفمبر 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Piper Sandler 37th Annual Healthcare Conference

19 نوفمبر 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

18 نوفمبر 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) in Oral and Poster Presentations at the AHA Scientific Sessions 2025

10 نوفمبر 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

06 نوفمبر 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Esperion Reports Third Quarter 2025 Financial Results and Provides Business Update

06 نوفمبر 2025 06:00:00 بحسب Nasdaq GlobeNewswire

Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

04 نوفمبر 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Jefferies Global Healthcare Conference - London

03 نوفمبر 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.

28 أكتوبر 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025

27 أكتوبر 2025 08:00:01 بحسب Nasdaq GlobeNewswire